Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD

Real-world study expands access to MDMA-assisted therapy for patients with PTSD and concurrent disor

Read More

Numinus builds on strong MAPS Phase 3 trial results through Compassionate Access Trial of MDMA for PTSD

[embed][/embed] Yesterday, MAPS announced significant, positive resul

Read More
Interior of a forest with dense trees and large rocks

Numinus Congratulates MAPS on Phase 3 Clinical Trial of MDMA for severe PTSD

[embed][/embed] 1 in 11 Canadians will suffer from PTS

Read More
Woman with dark, curly hair, staring at the lake with the sunlight reflected off the water in front of her

Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD

Cliquez ici pour la version française Numinus and Multidisciplinary Association for Psychedelic

Read More

Numinus and MAPS to Collaborate on MDMA Trial for PTSD

Vancouver-based firm Numinus announced yesterday it will collaborate with an arm of a longstanding n

Read More

Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support

Read More

Veterans Suffering from PTSD Find Relief Through Psilocybin

US Army Veteran Holly G. takes psilocybin to help make her combat-related PTSD more manageable. “K

Read More

We want to connect with you!

Sign up here so we can keep in touch.